Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PEITC for Lung Cancer Prevention in Smokers
NCT00691132Phase 2Completed
- Sponsor
- University of Minnesota
- Start
- Feb 2009
- Primary completion
- Jan 2013
- Modality
- Covalent Small Molecules, Classical Binding Small Molecules, Nucleic Acid-Directed Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of phenethyl isothiocyanate in lung cancer, sponsored by University of Minnesota. Started Feb 2009; status: completed.
02
Drugs
phenethyl isothiocyanate
03
Conditions
lung cancer
Beyond the preview
Go deeper on NCT00691132.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00691132.